Search Results Heading

MBRLSearchResults

mbrl.module.common.modules.added.book.to.shelf
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
    Done
    Filters
    Reset
  • Discipline
      Discipline
      Clear All
      Discipline
  • Is Peer Reviewed
      Is Peer Reviewed
      Clear All
      Is Peer Reviewed
  • Reading Level
      Reading Level
      Clear All
      Reading Level
  • Content Type
      Content Type
      Clear All
      Content Type
  • Year
      Year
      Clear All
      From:
      -
      To:
  • More Filters
      More Filters
      Clear All
      More Filters
      Item Type
    • Is Full-Text Available
    • Subject
    • Publisher
    • Source
    • Donor
    • Language
    • Place of Publication
    • Contributors
    • Location
64,318 result(s) for "Clearances"
Sort by:
Screening the system : exposing security clearance dangers
\"Screening the System shows how security clearance practices, including everything from background checks and fingerprinting to urinalysis and the polygraph, provide insight into the way we think about privacy, national security, patriotism, and the state\"-- Provided by publisher.
Population Pharmacokinetics of Therapeutic Monoclonal Antibodies
A growing number of population pharmacokinetic analyses of therapeutic monoclonal antibodies (mAbs) have been published in the scientific literature. The aims of this article are to summarize the findings from these studies and to relate the findings to the general pharmacokinetic and structural characteristics of therapeutic mAbs. A two-compartment model was used in the majority of the population analyses to describe the disposition of the mAb. Population estimates of the volumes of distribution in the central (V 1 ) and peripheral (V 2 ) compartments were typically small, with median (range) values of 3.1 (2.4–5.5) L and 2.8 (1.3–6.8) L, respectively. The estimated between-subject variability in the V 1 was usually moderate, with a median (range) coefficient of variation (CV) of 26% (12–84%). Between-subject variability in other distribution-related parameters such as the V 2 and intercompartmental clearance were often not estimated. Although the pharmacokinetic models used most frequently in the population analyses were models with linear clearance, other models with nonlinear, or parallel linear and nonlinear clearance pathways were also applied, as many therapeutic mAbs are eliminated via saturable target-mediated mechanisms. Population estimates of the maximum elimination rate (V max ) and the mAb concentration at which elimination was at half maximum for Michaelis-Menten-type elimination pathways varied considerably among the different therapeutic mAbs. However, estimates of the total clearance (CL) of mAbs with linear clearance characteristics and of the clearance of mAbs via the linear clearance pathway (CL L ) with parallel linear and nonlinear clearance were quite similar for the different mAbs and typically ranged from 0.2 to 0.5 L/day, which is relatively close to the estimated clearance of endogenous IgG of 0.21 L/day. The between-subject variability in the V max , CL and CL L was moderate to high, with estimated CVs ranging from 15% to 65%. Measures of body size were the covariates most commonly identified as influencing the pharmacokinetics of therapeutic mAbs. In summary, many features of the population pharmacokinetics of currently used therapeutic mAbs are similar, despite differences in their pharmacological targets and studied patient populations.
The influence of variable piston structure on the performance of magnetorheological dampers
Magnetorheological dampers (MRD) are widely used in many fields due to their fast response, high adjustability, and excellent vibration reduction performance. As a key component that directly affects the transmission of damping force within MRD, the optimization of the piston structure is of great significance for improving the damping adjustment range. In order to study the influence of piston structure on the damping performance of MRD output, a new type of MRD was designed based on the variable clearance piston structure in this paper. An experimental platform was built to test its performance under an external magnetic field. The damping clearance width D and piston plate length H were studied separately. The results showed that the maximum damping force that the damper with variable piston diameter D could output increased exponentially with the increase of D , while the maximum damping force that the damper with variable piston length H could output increased slowly with the increase of H .
Design of a Shield Tail Clearance Measuring Sensor for a Shield Machine
To improve the measurement accuracy and judge the distance between shield segments and shield tail accurately, the online monitoring technology of shield tail clearance was studied. Firstly, a sensor that can be used for shield tail clearance measurement was designed, and its key parts were selected. Secondly, the characteristics of the key parts were simulated to verify their feasibility. Finally, the monitoring principle was analyzed
Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy
Alzheimer’s disease (AD) is the most common neurodegenerative disease. Pathological proteins of AD mainly contain amyloid-beta (Aβ) and tau. Their deposition will lead to neuron damage by a series of pathways, and then induce memory and cognitive impairment. Thus, it is pivotal to understand the clearance pathways of Aβ and tau in order to delay or even halt AD. Aβ clearance mechanisms include ubiquitin–proteasome system, autophagy-lysosome, proteases, microglial phagocytosis, and transport from the brain to the blood via the blood-brain barrier (BBB), arachnoid villi and blood-CSF barrier, which can be named blood circulatory clearance. Recently, lymphatic clearance has been demonstrated to play a key role in transport of Aβ into cervical lymph nodes. The discovery of meningeal lymphatic vessels is another direct evidence for lymphatic clearance in the brain. Furthermore, periphery clearance also contributes to Aβ clearance. Tau clearance is almost the same as Aβ clearance. In this review, we will mainly introduce the clearance mechanisms of Aβ and tau proteins, and summarize corresponding targeted drug therapies for AD.
A degradative to secretory autophagy switch mediates mitochondria clearance in the absence of the mATG8-conjugation machinery
PINK1-Parkin mediated mitophagy, a selective form of autophagy, represents one of the most important mechanisms in mitochondrial quality control (MQC) via the clearance of damaged mitochondria. Although it is well known that the conjugation of mammalian ATG8s (mATG8s) to phosphatidylethanolamine (PE) is a key step in autophagy, its role in mitophagy remains controversial. In this study, we clarify the role of the mATG8-conjugation system in mitophagy by generating knockouts of the mATG8-conjugation machinery. Unexpectedly, we show that mitochondria could still be cleared in the absence of the mATG8-conjugation system, in a process independent of lysosomal degradation. Instead, mitochondria are cleared via extracellular release through a secretory autophagy pathway, in a process we define as Autophagic Secretion of Mitochondria (ASM). Functionally, increased ASM promotes the activation of the innate immune cGAS-STING pathway in recipient cells. Overall, this study reveals ASM as a mechanism in MQC when the cellular mATG8-conjugation machinery is dysfunctional and highlights the critical role of mATG8 lipidation in suppressing inflammatory responses. The mechanisms underlying mitochondrial quality control are not fully understood. Here the authors identify a switch from degradative to secretory autophagy in the absence of the mATG8-conjugation system, termed Autophagic Secretion of Mitochondria.
Experimental verification of dynamic behavior for multi-link press mechanism with 2D revolute joint considering dry friction clearances and lubricated clearances
The existence of clearance joints seriously affect the kinematic accuracy and service life of precision mechanisms. So as to ensure the kinematic accuracy reliability of mechanism, it is imperative to accurately predict the dynamic behavior of precision mechanism considering clearances. At present, the studies often focus on theoretical analysis and simulation verification of mechanism with clearances, while the studies verified by experiment are relatively few and often focus on simple mechanism. Moreover, most of studies centered on simple mechanism with dry friction clearance, while the studies on complex mechanism with multiple lubricated clearances are less. In this paper, the impact of multiple clearances on dynamic behavior of 2-DOF 9-bar precision press mechanism is analyzed. Firstly, the mathematical models of dry friction clearance and lubricated clearance are established and embedded into the Lagrange dynamic equation, respectively. Then, the impact of clearance values, the material of clearance-shaft and crank driving speeds on dynamic behavior of mechanism are researched. Finally, the simplified experimental platform of 2-DOF 9-bar press mechanism considering 2D revolute joint clearances is established, and the correctness of the theoretical model is proved by experimental verification. This study not only offers theoretical guidance for the layout and life prediction of multi-link press mechanism, but also provides reference for the dynamic behavior analysis and prediction of other mechanisms.
Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)
Early prediction of clearance mechanisms allows for the rapid progression of drug discovery and development programs, and facilitates risk assessment of the pharmacokinetic variability associated with drug interactions and pharmacogenomics. Here we propose a scientific framework – Extended Clearance Classification System (ECCS) – which can be used to predict the predominant clearance mechanism (rate-determining process) based on physicochemical properties and passive membrane permeability. Compounds are classified as: Class 1A – metabolism as primary systemic clearance mechanism (high permeability acids/zwitterions with molecular weight (MW) ≤400 Da), Class 1B – transporter-mediated hepatic uptake as primary systemic clearance mechanism (high permeability acids/zwitterions with MW >400 Da), Class 2 – metabolism as primary clearance mechanism (high permeability bases/neutrals), Class 3A –renal clearance (low permeability acids/zwitterions with MW ≤400 Da), Class 3B – transporter mediated hepatic uptake or renal clearance (low permeability acids/zwitterions with MW >400 Da), and Class 4 – renal clearance (low permeability bases/neutrals). The performance of the ECCS framework was validated using 307 compounds with single clearance mechanism contributing to ≥70% of systemic clearance. The apparent permeability across clonal cell line of Madin − Darby canine kidney cells, selected for low endogenous efflux transporter expression, with a cut-off of 5 × 10 −6  cm/s was used for permeability classification, and the ionization (at pH7) was assigned based on calculated pKa. The proposed scheme correctly predicted the rate-determining clearance mechanism to be either metabolism, hepatic uptake or renal for ~92% of total compounds. We discuss the general characteristics of each ECCS class, as well as compare and contrast the framework with the biopharmaceutics classification system (BCS) and the biopharmaceutics drug disposition classification system (BDDCS). Collectively, the ECCS framework is valuable in early prediction of clearance mechanism and can aid in choosing the right preclinical tool kit and strategy for optimizing drug exposure and evaluating clinical risk of pharmacokinetic variability caused by drug interactions and pharmacogenomics.
Study on nonlinear dynamics of rigid-flexible coupling multi-link mechanism considering various kinds of clearances
The revolute pair and translational pair are the two most important kinematic pairs in planar mechanism. Their clearances directly affect the accuracy of planar mechanism. In addition, flexible components will also lead to a certain degree of vibration and shaking of the mechanism, which will seriously affect the stability. In this paper, considering the coupling effect of revolute clearance pair, translational clearance pair and elastic deformation of components, an accurate dynamic modeling method of rigid-flexible coupling multi-link mechanism (MLM) considering revolute clearance and translational clearance is proposed to accurately predict the nonlinear behavior. Clearance models of revolute pair and translational pair are established, the flexible element model is established based on the absolute node coordinate formulation (ANCF), and the nonlinear dynamic equation of rigid-flexible coupling six-bar mechanism considering the clearance of revolute pair and translational pair is built by Lagrange multiplier method (LMD). Dynamic response and chaos identification are researched. Chaos identification is determined qualitatively and quantitatively by phase diagram, Poincaré map and largest Lyapunov exponent. Influences of different clearance values and driving speeds on nonlinear dynamic behavior of mechanism are discussed. Bifurcation diagrams varying with clearance size and driving velocity are studied, respectively. Dynamic modeling method is compared and verified by ADAMS. The experimental platform of six-bar mechanism is built to further verify the correctness of theoretical model.
Identification of direct connections between the dura and the brain
The arachnoid barrier delineates the border between the central nervous system and dura mater. Although the arachnoid barrier creates a partition, communication between the central nervous system and the dura mater is crucial for waste clearance and immune surveillance 1 , 2 . How the arachnoid barrier balances separation and communication is poorly understood. Here, using transcriptomic data, we developed transgenic mice to examine specific anatomical structures that function as routes across the arachnoid barrier. Bridging veins create discontinuities where they cross the arachnoid barrier, forming structures that we termed arachnoid cuff exit (ACE) points. The openings that ACE points create allow the exchange of fluids and molecules between the subarachnoid space and the dura, enabling the drainage of cerebrospinal fluid and limited entry of molecules from the dura to the subarachnoid space. In healthy human volunteers, magnetic resonance imaging tracers transit along bridging veins in a similar manner to access the subarachnoid space. Notably, in neuroinflammatory conditions such as experimental autoimmune encephalomyelitis, ACE points also enable cellular trafficking, representing a route for immune cells to directly enter the subarachnoid space from the dura mater. Collectively, our results indicate that ACE points are a critical part of the anatomy of neuroimmune communication in both mice and humans that link the central nervous system with the dura and its immunological diversity and waste clearance systems. Arachnoid cuff exit points create openings in the arachnoid barrier enabling the drainage of cerebrospinal fluid and exchange of molecules and cells between the dura and the subarachnoid space, therefore physically connecting the brain and the dura.